Evidence map›Paper›PMID 40945590›Full record

ArticleJournal of clinical epidemiology2025

International application of an optimized harmonization approach for longitudinal cognitive data in people with HIV.

Lang Lang, Leah H Rubin, Beau M Ances, Aggrey Anok, Sarah Cooley, Raha M Dastgheyb, Rebecca E Easter, Donald R Franklin, Robert K Heaton, Scott L Letendre and 7 more

Abstract read
In one paragraph

Article in Journal of clinical epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lang LangDepartment of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD, USA.
Leah H RubinDepartments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: yanxun.xu@jhu.edu.
Beau M AncesDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Aggrey AnokRakai Health Sciences Program, Kalisizo, Uganda.
Sarah CooleyDepartment of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
Raha M DastgheybDepartments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Rebecca E EasterDepartments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Donald R FranklinHIV Neurobehavioral Research Program, Departments of Medicine and Psychiatry, University of California San Diego, San Diego, CA, USA.
Robert K HeatonHIV Neurobehavioral Research Program, Departments of Medicine and Psychiatry, University of California San Diego, San Diego, CA, USA.
Scott L LetendreHIV Neurobehavioral Research Program, Departments of Medicine and Psychiatry, University of California San Diego, San Diego, CA, USA.
Gertrude NakijoziRakai Health Sciences Program, Kalisizo, Uganda.
Thomas MarcotteHIV Neurobehavioral Research Program, Departments of Medicine and Psychiatry, University of California San Diego, San Diego, CA, USA.
Robert PaulMissouri Institute of Mental Health, University of Missouri-St. Louis, St. Louis, Missouri, USA.
Eran F ShorerDepartments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Stephan TomusangeRakai Health Sciences Program, Kalisizo, Uganda.
David E VanceSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Yanxun XuDepartment of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD, USA; Division of Biostatistics and Bioinformatics at The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: lrubin@jhmi.edu.

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Savita Pahwa · 2007 to 2026
$33.8M
Therapeutic CoreP30MH075673 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Leah Helane Rubin · 2006 to 2026
$33.2M
MACS/WIHS Combined Cohort Study Clinical Research SiteU01HL146241 · NHLBI · EMORY UNIVERSITY · PI Cecile Delille Lahiri, Anandi Nayan Sheth · 2019 to 2026
$24.2M
NATIONAL NEUROLOGICAL AIDS BANKU24MH100929 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2013 to 2023
$12.5M
NCATS NIH HHS KL2 TR001432NCATS NIH HHS TL1 TR001431NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR001409NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1 TR003098NHLBI NIH HHS U01 HL146241NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI073961NIAID NIH HHS R01 AI197147NIDA NIH HHS 75N95023C00013NIMH NIH HHS HHSN271201000030CNIMH NIH HHS HHSN271201000036CNIMH NIH HHS N01MH22005NIMH NIH HHS P30 MH062512NIMH NIH HHS P30 MH075673NIMH NIH HHS P30 MH116867NIMH NIH HHS R01 MH073433NIMH NIH HHS R01 MH078748NIMH NIH HHS R01 MH099733NIMH NIH HHS R01 MH107345NIMH NIH HHS R01 MH118031NIMH NIH HHS R01 MH128085NIMH NIH HHS R24 MH129166NIMH NIH HHS U24 MH100925NIMH NIH HHS U24 MH100929NIMH NIH HHS U24 MH100930NINR NIH HHS R01 NR012907NINR NIH HHS R01 NR014449NINR NIH HHS R01 NR015738NSF 1918854
6 · The paper itself

Abstract

objectivesWe previously developed a refined longitudinal data harmonization method to address the challenge of nonoverlapping cognitive tests across cohorts, successfully harmonizing data from 5 large-scale US HIV studies. Building on this harmonized data set, we now aim to apply this method to an additional US HIV study and cognitive data from HIV studies in China, India, and Uganda. This effort will result in a more comprehensive data set with a larger, internationally diverse sample that includes both people with HIV and people without HIV. STUDY DESIGN AND

settingThe new cohorts to be harmonized included cognitive tests that did not fully overlap across studies, a challenge for traditional harmonization methods. We applied our refined approach, designed for scenarios without direct test linkage. In the Uganda cohort, where a key method assumption was violated, we implemented targeted adjustments.

resultsThe harmonized cognitive domain scores were consistent across cohorts and strongly correlated with raw or log-transformed cognitive test data (eg, timed outcomes). These scores preserved key patterns of variation observed in the raw data for key demographics-such as age, education, and race-and maintained age-related longitudinal trajectories of cognitive performance derived from all participants' visits.

conclusionThe resulting harmonized data set includes 18,270 participants across multiple countries, significantly enhancing its diversity and utility. It lays the groundwork for developing normative data and conducting more robust analyses to address critical neuro-HIV research questions. This study also demonstrates the adaptability of the refined harmonization method in integrating new data and accommodating methodological challenges. PLAIN LANGUAGE SUMMARY: People with HIV (PWH) often face a variety of cognitive challenges, but these issues can look different for each person. As different studies use different tests to measure cognitive abilities, it is difficult to combine the results from multiple studies and draw clear conclusions. In our previous work, we developed a refined method to harmonize data from 5 large US-based HIV neuro studies. Such method could handle the scenarios where nonoverlapping cognitive tests are used in certain domains across different studies. We now aim to include additional cohorts from the United States, China, India, and Uganda. Because these new cohorts also use nonoverlapping cognitive tests in certain domains, we applied our developed approach to harmonize the new data into our previously harmonized data. Our refined method created "harmonized scores" for cognitive abilities that closely matched the original test results. These scores captured differences related to age, education, and other factors while preserving how each person's cognitive abilities changed over time. By using this method to combine new data with existing data, we were able to create a more comprehensive and diverse data set. This will aid researchers to better understand the wide range of cognitive changes in PWH, leading to stronger, more inclusive studies on the impact of HIV on cognition.

Indexed as

CognitionHIV InfectionsAdultChinaFemaleHumansIndiaLongitudinal StudiesMaleMiddle AgedNeuropsychological TestsUgandaUnited StatesCognitionFactor modelHarmonizationHIVPsychometrics

Identifiers

PMID40945590
PMCPMC13295130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.